경도인지장애를 동반한 파킨슨병과 기억성 경도인지장애의 K-MoCA 인지 영역 비교
Comparison of Cognitive Domains in the Korean Version of Montreal Cognitive Assessment between Parkinson’s Disease with Mild Cognitive Impairment and Amnestic Mild Cognitive Impairment
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
본 연구는 Montreal Cognitive Assessment (MoCA)를 이용하여 구한 인지기능(지남력, 주의력, 언어기능, 시구성능력, 기억력 및 집행기능) 지수가 정상 노인, 파킨슨 경도인지장애(Mild Cognitive Impairment in Parkinson’s disease [PD-MCI]) 및 기억성 다영역 경도인지장애(amnestic multiple domain MCI [amMCI]) 환자 간 차이를 나타내는지 확인하고자 수행되었다. 정상 노인 30명, PD-MCI환자 30명 및 amMCI환자 30명이 연구에 참여하였고, 모든 대상자에게 한국판 MoCA를 실시하였다. 집단 간의 MoCA 총점과 인지영역 지수를 비교하기 위해 공변량분석(ANCOVA)을 실시한 결과, PD-MCI환자들은 MoCA의 총점, 기억력 및 집행기능 지수가 정상 노인에 비해 유의하게 낮은 것으로 확인되었다. amMCI환자들은 정상 노인과 비교하였을 때, 총점과 6개의 인지영역 지수가 모두 낮은 것으로 나타났다. 이러한 연구 결과는 MoCA의 총점을 확인하는 것보다 인지영역 지수를 살펴보는 것이 PD-MCI와 amMCI의 인지기능 결함에 대한 더 많은 정보를 제공한다는 것을 시사한다.
Abstract
This study investigated whether the cognitive domain index score (CDIS) obtained by the Montreal Cognitive Assessment (MoCA) showed differences between three groups: Normal elderly, Mild Cognitive Impairment in Parkinson’s disease (PD-MCI), and amnestic multiple domain MCI (amMCI) patients. The cognitive domains assessed included orientation, attention, language, visuospatial function, memory, and executive function. A total of 30 normal elderly, 30 PD-MCI patients, and 30 amMCI patients participated in the study. All participants were administered the Korean-MoCA. Covariance analyses were conducted to identify the group differences. In summary, PD-MCI patients showed significantly lower MoCA total, memory, and executive index scores than the normal elderly. The amMCI patients had a lower MoCA total score and six CDIS than normal elderly. These results suggest that MoCA-CDIS provides more information about the defect of cognitive function in the PD-MCI and the amMCI patients than the MoCA total score.
참고문헌 (35)
- 강연욱, "혈관성인지장애 선별검사로서 Korean-Montreal Cognitive Assessment(K-MoCA)의 신뢰도, 타당도 및 규준 연구", Korean Journal of Clinical Psychology, 28(2), pp.549~562 (2009)[DOI]
- 강연욱, "한국판 간이 정신상태검사" (2020), 학지사
- 강연욱, "서울신경심리검사" (2012), 휴브알엔씨
- 조맹제, "DSM-III-R 주요우울증에 대한 한국어판 Geriatric Depression Scale(GDS)의 진단적 타당성 연구", 신경정신의학, 38(1), pp.48~63 (1999)
- Aarsland, D., "Risk of dementia in Parkinson’s disease : A community-based, prospective study", Neurology, 56(6), pp.730~736 (2001)[DOI]
- Aarsland, D., "Mild cognitive impairment in Parkinson disease : A multicenter pooled analysis", Neurology, 75(12), pp.1062~1069 (2010)[DOI]
- Adler, C. H., "Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairment", Acta Neuropathologica, 120, pp.827~828 (2010)[DOI]
- Beatty, W. W., "Analyzing the subcortical dementia syndrome of Parkinson’s disease using the RBANS", Archives of Clinical Neuropsychology, 18(5), pp.509~520 (2003)[DOI]
- Bondi, M. W., "Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults", Neurology, 45(12), pp.2203~2206 (1995)[DOI]
- Bowles, N. L., "Aging and retrieval of words in semantic memory", Journal of Gerontology, 40(1), pp.71~77 (1985)[DOI]
- Chen, N. C., "Patterns of executive dysfunction in amnestic mild cognitive impairment", International Psychogeriatrics, 25(7), pp.1181~1189 (2013)[DOI]
- Christensen, K. J., "A cognitive battery for dementia : Development and measurement characteristics", Psychological Assessment : A Journal of Consulting and Clinical Psychology, 3(2), pp.168~ (1991)[DOI]
- Dalrymple-Alford, J. C., "The MoCA : Well-suited screen for cognitive impairment in Parkinson disease", Neurology, 75(19), pp.1717~1725 (2010)[DOI]
- Goetz, C. G., "Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale : Status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson’s disease", Movement Disorders, 19(9), pp.1020~1028 (2004)[DOI]
- Goldman, J. G., "Mild cognitive impairment in Parkinson’s disease", Minerva Medica, 102(6), pp.441~ (2011)
- Goldstein, F. C., "Incremental validity of Montreal Cognitive Assessment index scores in mild cognitive impairment and Alzheimer disease", Dementia and Geriatric Cognitive Disorders, 45(1-2), pp.49~55 (2018)[DOI]
- Hoops, S., "Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease", Neurology, 73(21), pp.1738~1745 (2009)[DOI]
- Hughes, A. J., "Accuracy of clinical diagnosis of idiopathic Parkinson’s disease : A clinicopathological study of 100 cases", Journal of Neurology, Neurosurgery & Psychiatry, 55(3), pp.181~184 (1992)[DOI]
- Julayanont, P., "Montreal Cognitive Assessment Memory Index Score(MoCA-MIS)as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease", Journal of the American Geriatrics Society, 62(4), pp.679~684 (2014)[DOI]
- Kasten, M., "Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease", Neurology, 75(5), pp.478~479 (2010)[DOI]
- Kaur, A., "The MoCA-Memory Index Score : An efficient alternative to paragraph recall for the detection of amnestic mild cognitive impairment", Alzheimer Disease & Associated Disorders, 32(2), pp.120~124 (2018)[DOI]
- Kim, H., "Validity of the Montreal Cognitive Assessment (MoCA) index scores: A comparison with the cognitive domain scores of the Seoul Neuropsychological Screening Battery (SNSB)", Dementia and Neurocognitive Disorders, 20(3), pp.28~37 (2021)[DOI]
- Litvan, I., "Diagnostic criteria for mild cognitive impairment in Parkinson’s disease : Movement Disorder Society Task Force guidelines", Movement Disorders, 27(3), pp.349~356 (2012)[DOI]
- Low, A., "Predictors And Patterns of Cognitive Decline Differ between PD-MCI And AD-MCI", Journal of Alzheimer’s Parkinsonism & Dementia, 3(1), pp.e27~ (2019)
- Mills, K. A., "Cognitive impairment in Parkinson’s disease : Associations between subjective and objective cognitive decline in a large longitudinal study", Parkinsonism & Related Disorders, 80, pp.127~132 (2020)[DOI]
- Morris, J. C., "The Clinical Dementia Rating(CDR)current version and scoring rules", Neurology, 43(11), pp.2412~2412 (1993)[DOI]
- Nasreddine, Z. S., "The Montreal Cognitive Assessment, MoCA : A brief screening tool for mild cognitive impairment", Journal of the American Geriatrics Society, 53(4), pp.695~699 (2005)[DOI]
- Petersen, R. C., "Mild cognitive impairment clinical trials", Nature Reviews Drug Discovery, 2(8), pp.646~653 (2003)[DOI]
- Salvadori, E., "Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment", Journal of Neurology, 260, pp.2220~2227 (2013)[DOI]
- Tierney, M. C., "Prediction of probable Alzheimer’s disease in memoryimpaired patients : A prospective longitudinal study", Neurology, 46(3), pp.661~665 (1996)[DOI]
- Williams-Gray, C. H., "Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort", Brain, 130(7), pp.1787~1798 (2007)[DOI]
- Winblad, B., "Mild cognitive impairment–beyond controversies, towards a consensus : Report of the International Working Group on Mild Cognitive Impairment", Journal of Internal Medicine, 256(3), pp.240~246 (2004)[DOI]
- Wood, J. L., "Montreal Cognitive Assessment(MoCA)performance and domainspecific index scores in amnestic versus aphasic dementia", Journal of the International Neuropsychological Society, 26(9), pp.927~931 (2020)[DOI]
- Yarnall, A. J., "Characterizing mild cognitive impairment in incident Parkinson disease : The ICICLE-PD study", Neurology, 82(4), pp.308~316 (2014)[DOI]
- Zheng, D., "The overall impairment of core executive function components in patients with amnestic mild cognitive impairment : A cross-sectional study", BMC Neurology, 12, pp.1~10 (2012)[DOI]
